Pharma Articles
Articles are written by renowned pharmaceutical company executives and other professionals from across the world on important topics relating to the business. The part of articles on the pharmaceutical industry focuses on current and developing concerns in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
Pharmaceutical Quality Management in Europe: GMP Systems, Quality Control and Manufacturing Standards
A tablet that works in a lab means little if the next batch is slightly different Pharmaceutical quality management exists to make sure every pack in every pharmacy matches the one that was tested and approved In Europe that promise is backed by one of the most mature regulatory frameworks in the wo...
Pharmaceutical Market Access and Reimbursement Strategies in Europe
Getting EMA approval is a milestone but it isnt a launch In Europe a medicine can be authorized in every member state and still not reach a single patient until each country agrees on its price and who pays for it That gap between approval and access is where pharmaceutical market access is won or l...
The Permanent Prescription: Why Gene Therapy Is Rewriting the Rules of Drug Safety
Gene therapy has moved from laboratory promise to clinical reality offering something medicine has rarely been able to promise before a single treatment capable of curing a disease rather than merely managing it Yet this same quality of permanence is quietly undermining the safety systems the pharma...
Beyond Trial Completion: Post-Trial Responsibilities and Effective Dissemination of Clinical Research
Clinical trials are the cornerstone of evidencebased medicine and pharmaceutical innovation Through the systematic evaluation of interventions they provide the evidence required to assess efficacy safety and value for patients and healthcare systems However the completion of participant followup doe...
Adaptive Trial Designs: Enhancing Speed and Decision-Making in Clinical Development
For decades the traditional clinical trial has followed a rigid script A protocol is written patients are enrolled the study runs to completion and only at the very end does the sponsor learn whether the investment paid off The model has served the industry well in terms of scientific rigour
Real-World Evidence in Pharmaceutical Drug Development
For most of the past halfcentury the randomised controlled trial has been the undisputed gatekeeper of pharmaceutical value It remains the gold standard for establishing causality and nothing in this article suggests otherwise Yet the controlled trial answers a narrow question under artificial condi...
European Pharmaceutical Legal Frameworks: Compliance, Legislation and Regulatory Obligations
If youve ever opened the EUs pharmaceutical rulebook and felt your eyes glaze over youre not alone Directives regulations guidelines delegated acts it can feel like reading a legal maze with no exit sign
Oligonucleotide Manufacturing: Scaling the Next Generation of Medicines
For most of their history oligonucleotides were manufactured the way specialty chemicals are made small batches high cost per gram and patient populations small enough that supply was rarely the limiting factor
Blockchain in Pharma: Strengthening Drug Traceability, Compliance, and Supply Chain Security
For most of the last decade the European pharmaceutical industry framed supply chain integrity as a packaging problem Put a unique identifier on every pack seal it with an antitampering device check it at the point of dispensing and the falsified medicine threat would be contained Since February th...
How M&A Is Reshaping Europe’s Pharmaceutical Pipeline
For most of the past halfcentury a European drugmakers future was written in its own laboratories That model has not disappeared but it has been joined and in many boardrooms overtaken by a second engine of growth the acquisition of externally discovered science